Bruce T. Adornato

3.2k total citations
36 papers, 2.3k citations indexed

About

Bruce T. Adornato is a scholar working on Neurology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Bruce T. Adornato has authored 36 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Neurology, 10 papers in Physiology and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Bruce T. Adornato's work include Botulinum Toxin and Related Neurological Disorders (6 papers), Pain Mechanisms and Treatments (5 papers) and Nerve injury and regeneration (4 papers). Bruce T. Adornato is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (6 papers), Pain Mechanisms and Treatments (5 papers) and Nerve injury and regeneration (4 papers). Bruce T. Adornato collaborates with scholars based in United States, Canada and Israel. Bruce T. Adornato's co-authors include Stuart C. Apfel, Nili Peylan‐Ramu, David G. Poplack, Giovanni Di Chiro, Philip A. Pizzo, Peter W. Lampert, Brent G. Petty, M. Wachsman, Dominick Sinicropi and Vinay Chaudhry and has published in prestigious journals such as Science, New England Journal of Medicine and JAMA.

In The Last Decade

Bruce T. Adornato

36 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce T. Adornato United States 19 860 748 587 399 209 36 2.3k
Don M. Long United States 27 530 0.6× 449 0.6× 611 1.0× 432 1.1× 264 1.3× 86 2.8k
T. Révész United Kingdom 21 780 0.9× 479 0.6× 1.7k 3.0× 377 0.9× 259 1.2× 52 2.7k
Tine V. Karlsen Norway 17 265 0.3× 772 1.0× 498 0.8× 349 0.9× 150 0.7× 35 2.1k
Toru Kawanami Japan 30 235 0.3× 578 0.8× 914 1.6× 688 1.7× 137 0.7× 92 2.4k
Nobuyuki Oka Japan 26 363 0.4× 1.1k 1.5× 1.2k 2.0× 378 0.9× 101 0.5× 102 2.5k
Steven S. Chin United States 23 617 0.7× 298 0.4× 1.1k 1.9× 319 0.8× 283 1.4× 64 2.3k
Daniel D. Mikol United States 33 1.2k 1.4× 544 0.7× 666 1.1× 495 1.2× 112 0.5× 93 4.9k
Pirkko Sonninen Finland 24 322 0.4× 543 0.7× 792 1.3× 381 1.0× 129 0.6× 44 2.1k
Robert B. Layzer United States 28 432 0.5× 430 0.6× 498 0.8× 853 2.1× 136 0.7× 61 2.5k
Adam M. H. Young United Kingdom 22 429 0.5× 329 0.4× 800 1.4× 912 2.3× 151 0.7× 62 3.4k

Countries citing papers authored by Bruce T. Adornato

Since Specialization
Citations

This map shows the geographic impact of Bruce T. Adornato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce T. Adornato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce T. Adornato more than expected).

Fields of papers citing papers by Bruce T. Adornato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce T. Adornato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce T. Adornato. The network helps show where Bruce T. Adornato may publish in the future.

Co-authorship network of co-authors of Bruce T. Adornato

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce T. Adornato. A scholar is included among the top collaborators of Bruce T. Adornato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce T. Adornato. Bruce T. Adornato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adornato, Bruce T., et al.. (2005). The failed lumbar puncture. Neurology. 64(7). 3 indexed citations
2.
Adornato, Bruce T., et al.. (2005). The failed lumbar puncture. Neurology. 64(7). E24–E24. 6 indexed citations
3.
Schifitto, Giovanni, Constantin T. Yiannoutsos, David M. Simpson, et al.. (2001). Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy. Neurology. 57(7). 1313–1316. 86 indexed citations
4.
Apfel, Stuart C., Bruce T. Adornato, Roy Freeman, et al.. (2000). Efficacy and Safety of Recombinant Human Nerve Growth Factor in Patients With Diabetic Polyneuropathy. JAMA. 284(17). 2215–2215. 274 indexed citations
5.
McArthur, Justin C., Constantin T. Yiannoutsos, David M. Simpson, et al.. (2000). A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. Neurology. 54(5). 1080–1088. 206 indexed citations
6.
Li, Kasey K., Nelson B. Powell, Clete A. Kushida, et al.. (1999). A Comparison of Asian and White Patients With Obstructive Sleep Apnea Syndrome. The Laryngoscope. 109(12). 1937–1940. 144 indexed citations
7.
Lew, Mark, Bruce T. Adornato, Drake D. Duane, et al.. (1997). Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia. Neurology. 49(3). 701–707. 181 indexed citations
8.
Petty, Brent G., David R. Cornblath, Bruce T. Adornato, et al.. (1994). The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Annals of Neurology. 36(2). 244–246. 318 indexed citations
9.
Warnick, Ronald E., Jack Raisanen, Bruce T. Adornato, et al.. (1993). Intracranial myxopapillary ependymoma: Case report. Journal of Neuro-Oncology. 15(3). 251–256. 28 indexed citations
10.
Herrick, Maie Kaarsoo, Yuan Chang, Dikran S. Horoupian, Charles Lombard, & Bruce T. Adornato. (1991). L-tryptophan and the eosinophilia-myalgia syndrome: Pathologic findings in eight patients. Human Pathology. 22(1). 12–21. 18 indexed citations
11.
Zonana, Jonathan, et al.. (1986). Familial porencephaly and congenital hemiplegia. The Journal of Pediatrics. 109(4). 671–674. 18 indexed citations
12.
Silverman, Earl D., Bruce T. Adornato, & John J. Miller. (1985). Eosinophilic fasciitis in a two‐year‐old child. Arthritis & Rheumatism. 28(8). 948–951. 5 indexed citations
13.
Hofmann, William W., Bruce T. Adornato, & Harald Reich. (1983). The relationship of insulin receptors to hypokalemic periodic paralysis. Muscle & Nerve. 6(1). 48–51. 15 indexed citations
14.
Liem, H. H., et al.. (1983). Hemopexin metabolism in patients with altered serum levels.. PubMed. 102(5). 838–46. 22 indexed citations
15.
Eiseman, Julie L., et al.. (1982). Effect of heme administration on hemopexin metabolism in the rhesus monkey.. PubMed. 100(3). 451–60. 11 indexed citations
16.
Adornato, Bruce T.. (1978). Depletion of Serum Hemopexin in Fulminant Rhabdomyolysis. Archives of Neurology. 35(8). 547–547. 8 indexed citations
17.
Adornato, Bruce T., Laurence Corash, & W. King Engel. (1977). Erythrocyte survival in Duchenne muscular dystrophy. Neurology. 27(11). 1093–1093. 14 indexed citations
18.
Adornato, Bruce T. & Bruce Berg. (1977). Diencephalic syndrome and von recklinghausen's disease. Annals of Neurology. 2(2). 159–160. 7 indexed citations
19.
Adornato, Bruce T.. (1976). Acute Renal Failure. Archives of Neurology. 33(10). 687–687. 4 indexed citations
20.
O’Brien, John S., Shintaro Okada, Dorothy L. Fillerup, et al.. (1971). Tay-Sachs Disease: Prenatal Diagnosis. Science. 172(3978). 61–64. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026